Culture‐positive sepsis · parenterally fed term and late preterm infants with surgical conditions
It is very uncertain whether fish oil LE changes culture‐positive sepsis compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Hypertriglyceridaemia · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
Conjugated bilirubin levels · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
ALP U/L · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
Mortality before hospital discharge · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
Neurodevelopmental outcomes · parenterally fed term and late preterm infants with surgical conditions
1 finding from 1 review
PNALD/ cholestasis (any definition) MOFS‐LE vs S‐LE Pure F‐LE vs S‐LE · parenterally fed term and late preterm infants
It is very uncertain whether fish oil LE changes PNALD/cholestasis (any definition) MOFS‐LE vs S‐LE Pure F‐LE vs S‐LE compared with non‐fish oil LE (very low certainty).
1 finding from 1 review
Use of ET (≥ 1); all studies · neonates with alloimmune hemolytic disease
It is very uncertain whether intravenous immunoglobulin plus phototherapy changes use of ET (≥ 1); all studies compared with phototherapy alone (very low certainty).
1 finding from 1 review
Use of ET (≥ 1); placebo‐controlled studies · neonates with alloimmune hemolytic disease
Intravenous immunoglobulin plus phototherapy showed no clear difference in use of ET (≥ 1); placebo‐controlled studies compared with phototherapy alone (moderate certainty).
1 finding from 1 review
ETs performed per infant; all studies · neonates with alloimmune hemolytic disease
1 finding from 1 review
ETs performed per infant; placebo‐controlled studies · neonates with alloimmune hemolytic disease
1 finding from 1 review
Use of top‐up transfusion in 1st week of life; all studies · neonates with alloimmune hemolytic disease
Intravenous immunoglobulin plus phototherapy showed no clear difference in use of top‐up transfusion in 1st week of life; all studies compared with phototherapy alone (low certainty).
1 finding from 1 review
Use of top‐up transfusion after 1st week of life; all studies · neonates with alloimmune hemolytic disease
It is very uncertain whether intravenous immunoglobulin plus phototherapy changes use of top‐up transfusion after 1st week of life; all studies compared with phototherapy alone (very low certainty).
1 finding from 1 review
Maximum total serum bilirubin (µmol/L); all studies · neonates with alloimmune hemolytic disease
1 finding from 1 review
Failure with primary modality of resuscitation · neonatal resuscitation
LMA probably leads to lower failure with primary modality of resuscitation compared with BMV (moderate certainty).
1 finding from 1 review
Death or HIE · neonatal resuscitation
LMA showed no clear difference in death or HIE compared with endotracheal intubation (low certainty).
1 finding from 1 review
Need for intubation · neonatal resuscitation
LMA probably leads to lower need for intubation compared with BMV (moderate certainty).
1 finding from 1 review
Apgar score ≤ 7 at 5 minutes · neonatal resuscitation
LMA probably leads to lower apgar score ≤ 7 at 5 minutes compared with BMV (moderate certainty).
1 finding from 1 review
Admission to neonatal intensive care unit · neonatal resuscitation
LMA probably leads to lower admission to NICU compared with BMV (moderate certainty).
1 finding from 1 review
Death or HIE · neonatal resuscitation
LMA showed no clear difference in death or HIE compared with BMV (low certainty).
1 finding from 1 review